James L. Mohler: Difference between revisions
clean up, added deadend tag, typo(s) fixed: Associate Director → associate director, Adjunct Professor → adjunct professor |
Hevexhexen (talk | contribs) No edit summary |
||
| Line 5: | Line 5: | ||
{{Dead end|date=January 2024}} |
{{Dead end|date=January 2024}} |
||
}} |
}} |
||
'''James Larue Mohler''' is a urologist at Roswell Park.[https://www.roswellpark.org/james-mohler]. James Mohler, MD, joined Roswell Park in 2003 as Chair of Urology and Leader of the Prostate Program. He became the associate director and Senior Vice President for Translational Research. He is Chair Emeritus, Urology, and Chief, Inter-Institutional Academics, and Professor of Oncology, at Roswell Park Comprehensive Cancer Center, and adjunct professor of Urology and Member of UNC-Lineberger Comprehensive Cancer Center at University of North Carolina. |
'''James Larue Mohler''' is a urologist at Roswell Park.[https://www.roswellpark.org/james-mohler]. James Mohler, MD, joined Roswell Park in 2003 as Chair of Urology and Leader of the Prostate Program. He became the associate director and Senior Vice President for [[Translational research|Translational Research]]. He is Chair Emeritus, Urology, and Chief, Inter-Institutional Academics, and Professor of Oncology, at Roswell Park Comprehensive Cancer Center, and adjunct professor of Urology and Member of UNC-Lineberger Comprehensive Cancer Center at University of North Carolina. |
||
When Dr. Mohler was in residency training about 30 years ago, the diagnosis of prostate cancer was the equivalent of a death sentence. "Back then, only 4% of prostate cancers we diagnosed were curable. Now, with PSA, the cure rate is between 80% and 90%," says Mohler.[https://www.roswellpark.org/cancertalk/201909/man-behind-psa-test] |
When Dr. Mohler was in residency training about 30 years ago, the diagnosis of prostate cancer was the equivalent of a death sentence. "Back then, only 4% of prostate cancers we diagnosed were curable. Now, with PSA, the cure rate is between 80% and 90%," says Mohler.[https://www.roswellpark.org/cancertalk/201909/man-behind-psa-test] |
||
Revision as of 12:06, 9 January 2024
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
James Larue Mohler is a urologist at Roswell Park.[1]. James Mohler, MD, joined Roswell Park in 2003 as Chair of Urology and Leader of the Prostate Program. He became the associate director and Senior Vice President for Translational Research. He is Chair Emeritus, Urology, and Chief, Inter-Institutional Academics, and Professor of Oncology, at Roswell Park Comprehensive Cancer Center, and adjunct professor of Urology and Member of UNC-Lineberger Comprehensive Cancer Center at University of North Carolina.
When Dr. Mohler was in residency training about 30 years ago, the diagnosis of prostate cancer was the equivalent of a death sentence. "Back then, only 4% of prostate cancers we diagnosed were curable. Now, with PSA, the cure rate is between 80% and 90%," says Mohler.[2]